MANENTI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 1.561
NA - Nord America 1.150
AS - Asia 605
SA - Sud America 130
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.483
Nazione #
US - Stati Uniti d'America 1.112
GB - Regno Unito 536
RU - Federazione Russa 323
IT - Italia 315
SG - Singapore 188
CN - Cina 164
IE - Irlanda 103
BR - Brasile 98
VN - Vietnam 98
DE - Germania 60
HK - Hong Kong 48
FR - Francia 47
SE - Svezia 46
FI - Finlandia 35
KR - Corea 30
UA - Ucraina 26
CA - Canada 20
NL - Olanda 19
IN - India 14
ZA - Sudafrica 14
MX - Messico 13
PL - Polonia 12
AR - Argentina 11
BD - Bangladesh 10
IQ - Iraq 8
BE - Belgio 7
CI - Costa d'Avorio 7
CZ - Repubblica Ceca 6
ID - Indonesia 6
KE - Kenya 6
LT - Lituania 6
AT - Austria 5
CO - Colombia 5
OM - Oman 5
EC - Ecuador 4
ES - Italia 4
JP - Giappone 4
TR - Turchia 4
UY - Uruguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CH - Svizzera 2
CL - Cile 2
EU - Europa 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 3.483
Città #
Southend 492
Dallas 163
Singapore 108
Dublin 101
Moscow 89
Houston 76
Ashburn 71
Fairfield 68
Santa Clara 67
Chandler 64
San Jose 62
Council Bluffs 48
Hong Kong 43
Siena 42
Hefei 41
Beijing 38
Milan 38
Ho Chi Minh City 32
Ann Arbor 30
Seattle 30
Seoul 30
Woodbridge 30
Los Angeles 29
Wilmington 27
Dong Ket 25
Munich 25
Florence 22
Helsinki 22
Jacksonville 21
New York 18
Cambridge 17
Princeton 15
Frankfurt am Main 14
Johannesburg 14
Lauterbourg 14
The Dalles 13
Rome 12
Nanjing 11
Hanoi 10
Montreal 10
San Diego 10
Warsaw 10
Buffalo 9
São Paulo 9
Chicago 8
Portsmouth 8
Abidjan 7
Bengaluru 7
Orem 7
Atlanta 6
Baghdad 6
Brussels 6
Lappeenranta 6
Nuremberg 6
Boardman 5
Brescia 5
Düsseldorf 5
Haiphong 5
Porto Alegre 5
Salt Lake City 5
San Mateo 5
Brno 4
Brooklyn 4
Cagliari 4
Denver 4
Mexico City 4
Monteriggioni 4
Nairobi 4
Newark 4
Phoenix 4
Tokyo 4
Toronto 4
Bari 3
Columbus 3
Da Nang 3
Kunming 3
Muscat 3
Málaga 3
Parma 3
Poplar 3
Recife 3
Redondo Beach 3
San Francisco 3
Trento 3
Turku 3
Abuja 2
Agliana 2
Alba 2
Barquisimeto 2
Belém 2
Bishkek 2
Bologna 2
Borgo San Lorenzo 2
Boston 2
Buon Ma Thuot 2
City of London 2
Cuenca 2
Guangzhou 2
Jakarta 2
Kathmandu 2
Totale 2.335
Nome #
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 546
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 371
Analyses of hemagglutinin (HA) specific antibody responses using different serological assays after three types of influenza vaccine in children and adults 310
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 297
Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination 262
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 243
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells 217
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 193
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 192
Sea buckthorn bud extract displays activity against cell-cultured Influenza virus 180
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 178
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 178
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 174
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees 127
Influenza D Virus: A Potential Threat for Humans? 63
Totale 3.531
Categoria #
all - tutte 10.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022231 37 32 25 14 12 11 10 4 11 15 26 34
2022/2023215 14 28 23 31 26 36 6 22 17 7 4 1
2023/2024208 6 4 12 7 8 33 93 11 6 8 6 14
2024/2025631 22 37 71 35 77 61 40 41 52 24 48 123
2025/20261.365 104 160 145 193 278 55 134 41 68 80 49 58
2026/202716 16 0 0 0 0 0 0 0 0 0 0 0
Totale 3.531